Gut
dysbiosis
has
been
associated
with
impaired
outcomes
in
liver
and
kidney
transplant
recipients,
but
the
gut
microbiome
of
lung
recipients
not
extensively
explored.
We
assessed
64
fecal
samples
from
end-stage
disease
patients
before
transplantation
219
after
using
metagenomic
sequencing.
To
identify
dysbiotic
microbial
signatures,
we
analyzed
243
age-,
sex-,
BMI-matched
healthy
controls.
By
unsupervised
clustering,
identified
five
groups
different
combinations
immunosuppressants
antibiotics
them
relation
to
microbiome.
Finally,
investigated
chronic
allograft
dysfunction
(CLAD)
stages
longitudinal
changes
transplantation.
found
108
species
(58.1%)
139
(74.7%)
that
were
differentially
abundant
compared
controls,
several
exhibiting
sharp
increases
Different
specific
signatures.
CLAD
stage
0
was
more
similar
controls
those
1.
diversity
remained
lower
than
average
up
20
years
post-transplantation.
dysbiosis,
already
present
exacerbated
following
transplantation.IMPORTANCEThis
study
provides
extensive
insights
into
which
warrants
further
investigation
can
be
used
for
microbiome-targeted
interventions
could
improve
outcome
Microorganisms,
Год журнала:
2022,
Номер
10(7), С. 1428 - 1428
Опубликована: Июль 14, 2022
The
gut
microbiota
(GM)
comprises
billions
of
microorganisms
in
the
human
gastrointestinal
tract.
This
microbial
community
exerts
numerous
physiological
functions.
Prominent
among
these
functions
is
effect
on
host
immunity
through
uptake
nutrients
that
strengthen
intestinal
cells
and
involved
immune
response.
GM
are
not
limited
to
gut,
but
bidirectional
interactions
between
various
extraintestinal
organs
have
been
identified.
These
termed
interorganic
axes
by
several
authors,
which
gut-brain,
gut-skin,
gut-lung,
gut-heart,
gut-metabolism
stand
out.
It
has
shown
an
organism
healthy
or
homeostasis
when
balance.
However,
altered
dysbiosis
represents
a
critical
factor
pathogenesis
many
local
systemic
diseases.
Therefore,
probiotics
intervene
this
context,
which,
according
published
studies,
allows
balance
be
maintained
GM,
leading
individual's
good
health.
International Journal of Molecular Sciences,
Год журнала:
2022,
Номер
23(9), С. 4768 - 4768
Опубликована: Апрель 26, 2022
Chronic
obstructive
pulmonary
disease
(COPD)
is
a
widespread
socially
significant
disease.
The
development
of
COPD
involves
the
innate
immune
system.
Interestingly,
regulation
lung
system
related
to
gut
microbiota.
This
connection
due
production
by
microorganisms
short-chain
fatty
acids
(SCFAs)
such
as
acetate,
propionate,
and
butyrate.
Nutritional
disturbances
changes
in
structure
intestinal
microbiota
lead
decrease
SCFAs
their
effect
on
immunity.
presence
metabolic
axis
linking
lungs
plays
an
important
role
pathogenesis
COPD.
In
addition,
nature
nutrition
may
participate
clinically
heterogeneous
course
Life,
Год журнала:
2023,
Номер
13(10), С. 2023 - 2023
Опубликована: Окт. 8, 2023
The
human
gut
microbiota
(GM)
is
a
complex
microbial
ecosystem
that
colonises
the
gastrointestinal
tract
(GIT)
and
comprised
of
bacteria,
viruses,
fungi,
protozoa.
GM
has
symbiotic
relationship
with
its
host
fundamental
for
body
homeostasis.
not
limited
to
scope
GIT,
but
there
are
bidirectional
interactions
between
other
organs,
highlighting
concept
"gut-organ
axis".
Any
deviation
from
normal
composition
GM,
termed
"microbial
dysbiosis",
implicated
in
pathogenesis
various
diseases.
Only
few
studies
have
demonstrated
modifications
disease
phenotypes,
it
still
unknown
whether
an
altered
contributes
or
simply
reflects
status.
Restoration
probiotics
prebiotics
been
postulated,
evidence
effects
limited.
Prebiotics
substrates
"selectively
utilized
by
microorganisms,
conferring
health
benefit".
This
study
highlights
vital
organs
demonstrates
dysbiosis
emergence
certain
representative
Finally,
this
article
focuses
on
potential
as
target
therapy
manipulate
presents
gaps
literature
research.
European Clinical Respiratory Journal,
Год журнала:
2025,
Номер
12(1)
Опубликована: Фев. 26, 2025
Background
and
aim
The
association
of
the
gut
microbiota
to
chronic
obstructive
pulmonary
disease
(COPD)
phenotypes
is
underexplored.
We
aimed
compare
stool
samples
from
patients
with
COPD
subjects
without
relate
findings
emphysema
status,
exacerbation
rate,
blood
eosinophil
levels,
symptom
score,
lung
function.
Antibiotics,
Год журнала:
2022,
Номер
11(4), С. 474 - 474
Опубликована: Апрель 1, 2022
Acute
and
chronic
lower
airway
disease
still
represent
a
major
cause
of
morbidity
mortality
on
global
scale.
With
the
steady
rise
multidrug-resistant
respiratory
pathogens,
such
as
Pseudomonas
aeruginosa
Klebsiella
pneumoniae,
we
are
rapidly
approaching
advent
post-antibiotic
era.
In
addition,
potentially
detrimental
novel
variants
viruses
continuously
emerge
with
most
prominent
recent
example
being
severe
acute
syndrome
coronavirus
2
(SARS-CoV-2).
To
this
end,
alternative
preventive
therapeutic
intervention
strategies
will
be
critical
to
combat
infections
in
future.
Chronic
diseases
associated
alterations
lung
gut
microbiome,
which
is
thought
contribute
progression
increased
susceptibility
infection
pathogens.
review
focus
how
modulating
harnessing
microbiome
may
pose
strategy
prevent
treat
pulmonary
well
disease.
Journal of Translational Medicine,
Год журнала:
2022,
Номер
20(1)
Опубликована: Июнь 21, 2022
Chronic
obstructive
pulmonary
disease
(COPD),
a
prevalent,
progressive
respiratory
disease,
has
become
the
third
leading
cause
of
death
globally.
Increasing
evidence
suggests
that
intestinal
and
microbiota
dysbiosis
is
associated
with
COPD.
Researchers
have
shown
T
helper
(Th)
17/regulatory
(Treg)
imbalance
involved
in
Qibai
Pingfei
Capsule
(QBPF)
traditional
Chinese
medicine
used
to
treat
COPD
clinically
China.
However,
effects
QBPF
intervention
on
Th17/Treg
balance
gut
lung
are
still
poorly
understood.This
study
divided
rats
into
three
groups
(n
=
8):
control,
model,
group.
After
establishing
model
for
four
weeks
administering
two
weeks,
Th17
cells,
Treg
their
cytokines,
transcription
factors,
were
analyzed.
Furthermore,
correlations
between
bacterial
genera
function
immune
measured.The
results
revealed
could
improve
contribute
new
rats.
Meanwhile,
treatment
regulate
composition
community
structure
rats,
suppressing
relative
abundance
Coprococcus_2,
Prevotella_9,
Blautia
Mycoplasma
lung,
but
accumulating
Prevotellaceae_UCG_003
Rikenellaceae_RC9_gut_group
lung.
Additionally,
gut-lung
axis
was
confirmed
by
significant
microbiota.
Functional
analysis
showed
amino
acid
metabolism
altered
Spearman
correlation
further
enriched
relationship
rats.Our
indicated
therapeutic
may
be
achieved
maintaining
cell
regulating
microbiota,
providing
references
explore
potential
biomarkers
possible
mechanism
Current Research in Immunology,
Год журнала:
2023,
Номер
4, С. 100065 - 100065
Опубликована: Янв. 1, 2023
The
studies
on
the
composition
of
human
microbiomes
in
healthy
individuals,
its
variability
course
inflammation,
infection,
antibiotic
therapy,
diets
and
different
pathological
conditions
have
revealed
their
intra
inter-kingdom
relationships.
lung
microbiome
comprises
major
species
members
phylum
Bacteroidetes,
Firmicutes,
Actinobacteria,
Fusobacteria
Proteobacteria,
which
are
distributed
ecological
niches
along
nasal
cavity,
nasopharynx,
oropharynx,
trachea
lungs.
Commensal
pathogenic
maintained
equilibrium
as
they
strong
Bacterial
overgrowth
after
dysbiosis
and/or
imbalanced
CD4+
helper
T
cells,
CD8+
cytotoxic
cells
regulatory
(Treg)
populations
can
promote
inflammatory
reactions
distress,
consequently
acute
chronic
respiratory
diseases.
This
review
is
aimed
to
summarize
latest
advances
resident
participation
most
common
pulmonary
infections
pneumonia,
community-acquired
pneumonia
(CAP),
ventilator-associated
(VAP),
immunodeficiency
associated
SARS-CoV-2-associated
distress
syndrome
(ARDS)
obstructive
disease
(COPD).
We
briefly
describe
physiological
immunological
mechanisms
that
selectively
create
advantages
or
disadvantages
for
relative
growth
bacterial
tract.
At
end,
we
propose
some
directions
analytical
methods
may
facilitate
identification
key
genera
transient
microbes
involved
diseases'
initiation
progression.
Animal nutrition,
Год журнала:
2024,
Номер
18, С. 322 - 339
Опубликована: Май 17, 2024
Short
chain
fatty
acids
(SCFA)
exist
in
dietary
foods
and
are
produced
by
the
fermentation
of
gut
microbiota,
considered
an
important
element
for
regulating
host
health.
Through
blood
circulation,
SCFA
obtained
from
have
impact
on
intestinal
health
as
well
vital
organs
host.
It
has
been
recognized
that
is
"vital
organ"
As
microbial
metabolites,
could
create
"axis"
connecting
to
other
organs.
Therefore,
"gut-organ
axes"
become
a
focus
research
recent
years
analyze
organism
In
this
review,
we
summarized
sources,
absorption
properties,
function
both
peripheral
tissues
(brain,
kidney,
liver,
lung,
bone
cardiovascular)
way
axes".
exert
beneficial
pathological
role
various
ways,
which
effects
more
pronounced.
addition,
reflected
preventive
therapeutic
effects.
More
importantly,
mechanisms
behinds
provided
insight
into
SCFA,
assisting
development
novel
strategies
maintaining
Probiotics and Antimicrobial Proteins,
Год журнала:
2024,
Номер
unknown
Опубликована: Июнь 12, 2024
Abstract
Chronic
obstructive
pulmonary
disease
(COPD)
is
the
world's
leading
lung
and
lacks
effective
specific
clinical
strategies.
Probiotics
are
increasingly
used
to
support
improvement
of
course
inflammatory
diseases.
In
this
study,
we
evaluated
potential
a
lactic
acid
bacteria
(LAB)
combination
containing
Limosilactobacillus
reuteri
GMNL-89
Lacticaseibacillus
paracasei
GMNL-133
decrease
inflammation
emphysema
in
COPD
mouse
model.
This
model
was
induced
by
intranasal
stimulation
with
elastase
LPS
for
4
weeks,
followed
2
weeks
oral
LAB
administration.
The
results
showed
that
decreased
reduced
cytokines
(IL-1β,
IL-6,
TNF-α)
tissue
mice.
Microbiome
analysis
revealed
Bifidobacterium
Akkermansia
muciniphila
,
gut
mice,
could
be
restored
after
treatment.
Microbial
α-diversity
lungs
mice
but
reversed
administration,
which
also
increased
relative
abundance
Candidatus
arthromitus
Burkholderia
lungs.
Furthermore,
LAB-treated
exhibited
levels
short-chain
fatty
acids,
specifically
acetic
propionic
acid,
cecum.
Additionally,
negatively
correlated
C.
Adlercreutzia
levels.
conclusion,
L.
demonstrates
beneficial
effects
on
experimental
correlating
changes
microbiota,
providing
strategy
future
adjuvant
therapy.